Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology. // Journal of Neuroimmunology. – URL: https://www.sciencedirect.com/science/article/pii/S0165572826002791?dgcid=rss_sd_all
Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology. Journal of Neuroimmunology. https://www.sciencedirect.com/science/article/pii/S0165572826002791?dgcid=rss_sd_all
“Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology.” Journal of Neuroimmunology.
@article{article54161,
title = {Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology},
journal = {Journal of Neuroimmunology},
url = {https://www.sciencedirect.com/science/article/pii/S0165572826002791?dgcid=rss_sd_all}
}